Epidermal growth factor receptor signaling and the progression of diabetic nephropathy

By  

Journal Of Diabetes Investigation, Vol. 6, Iss. 5, 2015-09 ,pp. : 519-521

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy

By  

Journal Of Diabetes Investigation, Vol. 6, Iss. 3, 2015-05 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

N.N. Timofeev, Gipobioz i kriobioz. proshloe, nastoyashchee i budushchee (Hypobiosis and cryobiosis: The past, present, and future), Moscow, Inform-Znanie, 2005

By Medvedev V.  

Human Physiology, Vol. 32, Iss. 5, 2006-10 ,pp. : 629-630

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Targeted Metabolomics Reveals Hippurate as a Urinary Potential Marker for Diabetic Nephropathy

By  

Current Metabolomics, Vol. 4, Iss. 2, 2016-06 ,pp. : 121-128

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced glycation end products and diabetic nephropathy: a comparative study using diabetic and normal rats with methylglyoxal-induced glycation

By Rodrigues Lisa   Matafome Paulo   Crisóstomo Joana   Santos-Silva Daniela   Sena Cristina   Pereira Paulo   Seiça Raquel  

Journal of Physiology and Biochemistry, Vol. 70, Iss. 1, 2014-03 ,pp. : 173-184

Springer Publishing Company

Access to resources Recommend Favorite